n-methyl-3,4-methylenedioxyamphetamine has been researched along with vanoxerine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, HS; Wang, RY | 1 |
| Brodkin, J; Nash, JF | 1 |
| Galloway, MP; Koch, S | 1 |
| Camarero, J; Colado, MI; Esteban, B; Green, AR; O'Shea, E | 1 |
| Colado, MI; Elliott, JM; Esteban, B; Green, AR; Mechan, AO; O'Shea, E | 1 |
| Camarero, J; Colado, MI; Green, AR; O'Shea, E; Sanchez, V | 1 |
| Callaghan, PD; Daws, LC; Irvine, RJ | 1 |
| Aguirre, N; Goñi-Allo, B; Herv'as, I; Lasheras, B; Ramos, M | 1 |
| Arrant, AE; Caster, JM; Kuhn, CM; Morris, SE; Nagel, JM; Parylak, S; Walker, QD; Zhou, G | 1 |
9 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and vanoxerine
| Article | Year |
|---|---|
MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Cerebral Cortex; Electrophysiology; Fluoxetine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Stereoisomerism; Stereotaxic Techniques | 1991 |
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Fluoxetine; Ketanserin; Male; Mazindol; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Serotonin | 1991 |
MDMA induced dopamine release in vivo: role of endogenous serotonin.
Topics: Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; In Vitro Techniques; Ketanserin; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists | 1997 |
Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Temperature; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Homovanillic Acid; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 2001 |
The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Animals; Benzazepines; Body Temperature; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Fever; Hallucinogens; Hippocampus; Male; Methysergide; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Remoxipride; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2002 |
Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum.
Topics: Animals; Ascorbic Acid; Body Temperature; Calcium; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Ferrous Compounds; Free Radicals; Hydroxybenzoates; Lipid Peroxidation; Male; Mice; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Rats; Salicylic Acid; Synaptosomes; Time Factors | 2002 |
Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry.
Topics: Amphetamines; Animals; Calibration; Dose-Response Relationship, Drug; Electrochemistry; Electrodes; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Oxidation-Reduction; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Zimeldine | 2005 |
Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
Topics: Amphetamine-Related Disorders; Animals; Body Temperature Regulation; Cell Survival; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Hallucinogens; Male; Malonates; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Piperazines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 2006 |
Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.
Topics: Aging; Amphetamines; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Electrophysiology; Male; Methylphenidate; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Nomifensine; Piperazines; Rats; Rats, Sprague-Dawley | 2010 |